首页 > 市场调查报告书 > 製药

疫苗动物用医药

市场调查报告书

商品编码

1461337

兽用疫苗市场，依动物类型、技术、给药途径、配销通路、地理位置

Veterinary Vaccines Market, By Animal Type, By Technology, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2024年03月19日 | 出版商:

Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年兽用疫苗市场价值为97亿美元，预计到2031年将达到161.7亿美元，2024年至2031年的年复合成长率(CAGR)为7.6%。

报告范围		报告详情
基准年：	2023年	2023/2024 年市场规模：	97亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测期间 2023/2024 至 2030/2031 年复合成长率：	7.60%	2030/2031 价值预测：	161.7 亿美元

兽用疫苗市场占有率 (%)，按地区，2024 年

兽用疫苗是给予动物的生物製剂，旨在刺激免疫系统并提供对疾病的主动免疫力。疫苗接种可以保护个别动物免受传染病的侵害，并产生群体免疫力，从而间接保护整个社区。随着宠物成为人们家庭不可分割的一部分，动物保健意识不断增强，全球兽用疫苗市场在过去几十年呈现快速扩张。各国政府也鼓励牲畜和伴侣动物进行疫苗接种。疫苗接种技术和重组程序的进步使製造商能够开发出针对多种人畜共通传染病的有效疫苗。

市场动态：

全球兽用疫苗市场受到宠物饲养量增加、动物保健支出增加、政府动物疾病控制措施、人畜共通传染病风险增加以及畜牧业集约化等因素的推动。然而，疫苗生产成本高昂、监管严格以及某些地区缺乏必要的基础设施和专业知识限制了市场成长。递送系统、治疗方法和表位作图的进步为兽用疫苗市场提供了机会。製药公司正在开发重组蛋白和抗毒素，以有效预防猪瘟、禽流感、狂犬病和牛结核病，这些疾病是动物和公众健康的主要威胁。引入单剂量製剂和整合式无针注射器旨在降低疫苗接种成本并提高便利性。

研究的主要特点：

该报告对全球兽用疫苗市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数介绍了全球兽用疫苗市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球兽用疫苗市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球兽用疫苗市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
东协
澳洲
韩国
亚太地区其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
北非
中非
南非

第 10 章：竞争格局

Aratana Therapeutics, Inc.
Regeneus Ltd.
Morphogenesis, Inc.
Karyopharm Therapeutics, Inc.
Zoetis, Inc.
Eli Lilly and Company
Merck & Co., Inc.
Boehringer Ingelheim GmbH

第 11 章：分析师观点

命运之轮
分析师观点
连贯的机会图

第 12 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI125

The veterinary vaccines market is estimated to be valued at USD 9.70 Bn in 2024 and is expected to reach USD 16.17 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 9.70 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	7.60%	2030/2031 Value Projection:	US$ 16.17 Bn

Veterinary Vaccines Market Share (%), By Region, 2024

Veterinary vaccines are biological preparations administered to animals in order to stimulate the immune system and provide active immunity against a disease. Vaccination protects individual animals from infectious diseases and generates herd immunity which indirectly protects the whole community. The global veterinary vaccine market has shown rapid expansion over the past few decades driven by the increasing awareness about animal healthcare as pets have become an integral part of people's families. Government mandates in various countries have also encouraged vaccination of livestock and companion animals. Advancements in vaccination technologies and recombinant procedures have enabled manufacturers to develop efficacious vaccines against a wide range of zoonotic diseases.

Market Dynamics:

The global veterinary vaccine market is driven by factors such as rising pet adoption, growing animal healthcare expenditure, government initiatives for animal disease control, increase in the risk of zoonotic diseases, and intensification of livestock farming. However, high cost of vaccine production, stringent regulations and lack of necessary infrastructure and expertise in some regions constrain market growth. Advancements in delivery systems, therapeutic approaches, and epitope mapping offer opportunities in the veterinary vaccines market. Pharmaceutical companies are developing recombinant protein and antitoxins for effective vaccination against swine fever, bird flu, rabies, and bovine tuberculosis which are major threats to animals as well as public health. Introduction of single-dose formulations and integrated needle-free injectors aim to reduce vaccination costs and improve convenience.

Key Features of the Study:

This report provides an in-depth analysis of the global veterinary vaccines market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global veterinary vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Aratana Therapeutics Inc., Regeneus Ltd., Morphogenesis Inc., Karyopharm Therapeutics Inc., Zoetis Inc., Eli Lilly and Company, Merck & Co. Inc., Boehringer Ingelheim GmbH., Elanco Animal Health, Virbac, Hester Biosciences Limited, Ceva Sante Animale, Phibro Animal Health Corporation, Kemin Industries, Inc., Finlab, Vaxxinova , Vira Vaccine Shaya, and VETERQUIMICA SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global veterinary vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary vaccines market.

Market Segmentation

Technology:
- Inactivated Vaccines
- Toxoid Vaccines
- Live Attenuated Vaccines
- Subunit and DNA Vaccines
- Recombinant Vaccines
Animal Type:
- Companion
- Equine
- Canine
- Feline
- Livestock
- Bovine
- Ovine
- Porcine
- Poultry
- Others
Route of Administration:
- Subcutaneous Injection
- Intramuscular Injection
- Intranasal Administration
- Others
Distribution Channel
- Public
- Private
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Aratana Therapeutics Inc.
- Regeneus Ltd.
- Morphogenesis Inc.
- Karyopharm Therapeutics Inc.
- Zoetis Inc.
- Eli Lilly and Company
- Merck & Co. Inc.
- Boehringer Ingelheim GmbH.
- Elanco Animal Health
- Virbac
- Hester Biosciences Limited
- Ceva Sante Animale
- Phibro Animal Health Corporation
- Kemin Industries, Inc.
- Finlab
- Vaxxinova
- Vira Vaccine Shaya
- VETERQUIMICA SA

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Animal Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
PEST Analysis

4. Global Veterinary Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the Market

5. Global Veterinary Vaccine Market, By Technology, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Inactivated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Toxoid Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Live Attenuated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Subunit and DNA Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Recombinant Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

6. Global Veterinary Vaccine Market, By Animal Type, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Companion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Equine
Canine
Feline
Livestock
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Bovine
Ovine
Porcine
Poultry
Others

7. Global Veterinary Vaccine Market, By Route of Administration, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Subcutaneous Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Intramuscular Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Intranasal Administration
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

8. Global Veterinary Vaccine Market, By Distribution Channel, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

9. Global Veterinary Vaccine Market, By Region, 2019 - 2031, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (US$ Billion)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Aratana Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Regeneus Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Morphogenesis, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Karyopharm Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zoetis, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Boehringer Ingelheim GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies